3EWJ
Crystal structure of catalytic domain of TACE with carboxylate inhibitor
3EWJ の概要
| エントリーDOI | 10.2210/pdb3ewj/pdb |
| 関連するPDBエントリー | 1bkc 2fv9 3e8r |
| 関連するBIRD辞書のPRD_ID | PRD_000919 |
| 分子名称 | ADAM 17, ZINC ION, N-{(2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl}-3-methyl-L-valyl-N-(2-aminoethyl)-L-alaninamide, ... (5 entities in total) |
| 機能のキーワード | tace, adam17, hydrolase, cleavage on pair of basic residues, glycoprotein, membrane, metal-binding, metalloprotease, notch signaling pathway, phosphoprotein, protease, sh3-binding, transmembrane, zymogen |
| 由来する生物種 | Homo sapiens (Human) |
| 細胞内の位置 | Membrane; Single-pass type I membrane protein: P78536 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 62347.39 |
| 構造登録者 | |
| 主引用文献 | Guo, Z.,Orth, P.,Wong, S.C.,Lavey, B.J.,Shih, N.Y.,Niu, X.,Lundell, D.J.,Madison, V.,Kozlowski, J.A. Discovery of novel spirocyclopropyl hydroxamate and carboxylate compounds as TACE inhibitors. Bioorg.Med.Chem.Lett., 19:54-57, 2009 Cited by PubMed Abstract: We have discovered nanomolar inhibitors of TNF-alpha convertase (TACE) comprised of a novel spirocyclic scaffold and either a carboxylate or hydroxamate zinc binding moiety. X-ray crystal structures and computer models of selected compounds binding to TACE explain the observed SAR. We report the first TACE X-ray crystal structure for an inhibitor with a carboxylate zinc ligand. PubMed: 19054672DOI: 10.1016/j.bmcl.2008.11.034 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.8 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






